Skip to main content
SpringerLink
Log in

Comparative animal studies on cardiovascular toxicity of tri- and tetracyclic antidepressants and citalopram; relation to drug plasma levels

  • Original Investigations
  • Published:
Psychopharmacology Aims and scope Submit manuscript

Abstract

The aim of the present study was to compare cardiovascular and/or cardiotoxic effects of eight anti-depressants (imipramine, chlorimipramine, amitriptyline, nortriptyline, doxepin, maprotiline, mianserin and citalopram) in anaesthetized cats after oral dosing and in conscious rabbits after intravenous infusion. In the cats drug plasma levels were determined as well. When estimated from ECG recordings, citalopram and chlorimipramine in particular, but also mianserin, appeared less cardiotoxic than the other drugs tested. The cardiovascular effects seen in the cats were with few exceptions identical for all the drugs tested but not seen at the same dose (concentration). Safety margins were defined as minimal doses or plasma levels when ECG changes (conduction or rhythm) or cardiovascular effects (±10% change of initial value in a series of parameters) occurred in experimental animals divided by maximal therapeutic dose or mean plasma levels in patients. From comparisons of the safety margins it is concluded that except for citalopram and mianserin (safety margins 80 and 18 respectively in cats and >15 in rabbits) all the other drugs tested (safety margins ≤9) have a cardiotoxic potential. The probability that cardiovascular side effects may occur is less pronounced for citalopram (safety margins 10–32) than for all the other drugs tested (safety margins ranging from 0.1 to <5).

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  • Andersson K-E, Carlström S, Gustafson A (1971) Arytmier vid intoxikationer med tricykliska tymoleptika och fentiaziner. Läkartidningen 68:Suppl II, 74–82

    Google Scholar 

  • Barnes RJ, Kong SM, Wu RWU (1968) Electrocardiographic changes in amitriptyline poisoning. Br Med J 3:222–223

    Google Scholar 

  • Barth N, Muscholl E (1974) The effects of the tricyclic anti-depressants desipramine, doxepin and iprindole on the isolated perfused rabbit heart. Naunyn-Schmiedeberg's Arch Pharmacol 284:215–232

    Google Scholar 

  • Barth N, Muscholl E (1976) Die Rolle adrenerger Mechanismen bei der Entstehung von Arrhythmien nach Einnahme trizyklischer Antidepressiva. Dtsch Med Wschr 101:88–90

    Google Scholar 

  • Baumann PA, Maitre L (1977) Blockade of presynaptic alpha receptors and of amine uptake in the rat brain by the antidepressant mianserin. Arch Pharmacol 300:31–37

    Google Scholar 

  • Boeck V, Jørgensen A (1980) Electrocardiographic and cardiovascular changes in cats and dogs caused by high doses of amitriptyline given as conventional tablets or a sustained release preparation. acta Pharmacol Toxicol 46:161–170

    Google Scholar 

  • Boeck V, Fredricson Overø K, Svendsen O (1982) Studies on acute toxicity and drug levels of citalopram in the dog. Acta Pharmacol Toxicol 50:169–174

    Google Scholar 

  • Bretschneider HJ, Martel J, Hellige G, Hensel I, Kettler D (1972) Korrelation des endosystolischen Ventrikel-Volumens pro Gewichtseinheit (ESV/100 g) zu Potenzfunktionen des arteriellen Druckes (P) und der ventrikulären Druckanstiegsgeschwindigkeit (dp/dt max). Verhandlungen der Deutschen Gesellschaft für Kreislaufforschung 38:233–237

    Google Scholar 

  • Brorson L, Wennerblom B (1978) Electrophysiological methods in assessing cardiac effect of the tricyclic antidepressant imipramine. Acta Med Scand 203:429–432

    Google Scholar 

  • Brogden RN, Hell RC, Speight TM, Avery GS (1978) Mianserin: A review of its pharmacological properties and therapeutic efficacy in depressive illness. Drugs 16:273–301

    Google Scholar 

  • Burrows GD, Vohra J, Hunt D, Sloman JG, Scoggins BA, Davies B (1976) Cardiac effects of different tricyclic antidepressant drugs. Br J Psychiatry 129:335–341

    Google Scholar 

  • Cassem N (1982) Cardiovascular effects of antidepressants. J Clin Psychiatry 43:22–28

    Google Scholar 

  • Christensen AV, Fjalland B, Pedersen V, Danneskiold-Samsøe P, Svendsen O (1977) Pharmacology of a new phthalane (Lu 10-171), with specific 5-HT uptake inhibiting properties. Eur J Pharmacol 41:153–162

    Google Scholar 

  • Elonen E (1974) Correlation of the cardiotoxicity of tricyclic antidepressants to their membrane effects. Med Biol 52: 415–423

    Google Scholar 

  • Elonen E, Mattila MJ, Saarnivaara L (1974) Cardiovascular effects of amitriptyline, nortriptyline, protriptyline and doxepin in conscious rabbits. Eur J Pharmacol 28:178–188

    Google Scholar 

  • Fredricson Overø K (1978) Preliminary studies of the kinetics of citalopram in man. Eur J Clin Pharmacol 14:69–73

    Google Scholar 

  • Fredricson Overø K (1982) Kinetics of citalopram in man; plasma levels in patients. Prog Neuro-Psychopharmacol Biol Psychiatry 6:311–318

    Google Scholar 

  • Gastpar M, Gastpar G (1982) Preliminary experience with citalopram (Lu 10-171), a specific 5-HT-re-uptake inhibitor, as antidepressant. Prog Neuro-Psychopharmacol Biol Psychiatry 6:319–325

    Google Scholar 

  • Gottlieb P, Wandall T, Frericson Overø K (1980) Initial, clinical trial on a new, specific 5-HT reuptake inhibitor, citalopram (Lu 10-171). Acta Psychiatr Scand 62:236–244

    Google Scholar 

  • Hollister L (1982) 3rd International Meeting on Clinical Pharmacology in Psychiatry, Hindsgavl 14–17 June

  • Hyttel J (1977) Neurochemical characterization of a new potent and selective serotonin uptake inhibitor, Lu 10-171. Psychopharmacology 51:225–233

    Google Scholar 

  • Hyttel J (1982) Citalopram. Pharmacological profile of a specific serotonin uptake inhibitor with antidepressant activity. Prog Neuro-Psychopharmacol Biol Psychiatry 6:277–295

    Google Scholar 

  • Jefferson JW (1975) A review of the cardiovascular effects and toxicity of tricyclic antidepressants. Psychosom Med 37:160–179

    Google Scholar 

  • Jørgensen A (1975) A gas chromatographic method for the determination of amitriptyline and nortriptyline in human serum. Acta Pharmacol Toxicol 36:79–80

    Google Scholar 

  • Köhler E, Greeff K (1972) Der Einfluß kreislaufwirksamer Pharmaka auf dp/dt max und VCE max des linken Ventrikels. Verhandlungen der Deutschen Gesellschaft für Kreislaufforschung 38:246–251

    Google Scholar 

  • Manoguerra AS, Weaver LC (1977) Poisoning with tricyclic antidepressant drugs. Clin Toxicol 10:149–158

    Google Scholar 

  • Moir DC, Crooks J, Cornwell WB, O'Malley K, Dingwall-Fordyce I, Turnbull MJ, Weir RD (1972) Cardiotoxicity of amitriptyline. Lancet II:561–564

    Google Scholar 

  • Moccetti T (1977) Kardiotoxische Medikamente unter besonderer Berücksichtigung der Phenothiazine und Imipraminderivate. Hans Huber, Bern

    Google Scholar 

  • Pedersen OL, Gram LF, Kristensen CB, Møller M, Thaysen P, Bjerre M, Kragh-Sørensen P, Klitgaard NA, Seridrup E, Hole P, Brinkløv M (1982a) Overdosage of antidepressants: Clinical and pharmacokinetic aspects. Eur J Clin Pharmacol 23:513–521

    Google Scholar 

  • Pedersen O, Lindegaard, Kragh-Sørensen P, Bjerre M, Fredricson Overø, K, Gram LF (1982b) Citalopram, a selective serotonin reuptake inhibitor, clinical, antidepressive and long-term effect. Psychopharmacology 77:199–204

    Google Scholar 

  • Pinder RM, Brogden RN, Speight TM, Avery GS (1977) Maprotiline: A review of its pharmacological proties and therapeutic efficacy in mental depressive states. Drugs 19:321–352

    Google Scholar 

  • Preskorn SH, Irwin HA (1982) Toxicity of tricyclic antidepressants, mechanism, intervention. A review. J Clin Psychiatry 43: 151–156

    Google Scholar 

  • Rasenack U, Gattenlöhner W (1976) Trizyklische Antidepressiva: Klinik und Therapie der Intoxikation. Dtsch Med Wschr 101:1165–1168

    Google Scholar 

  • Risch SC, Groom GP, Janowsky DS (1982) The effects of psychotropic drugs on the cardiovascular system. J Clin Psychiatry 43:16–31

    Google Scholar 

  • Shaw WL (1980) The comparative safety of mianserin in overdose. Curr Med Res Opin 6, suppl 7:44–51

    Google Scholar 

  • Thorstrand C (1976) Clinical features in poisonings by tricyclic antidepressants with special reference to the ECG. Acta Med Scand 199:337–546

    Google Scholar 

  • Warner HR, Swan HJC, Conolly DC, Tomkins RC, Wood EH (1953) Quantitation of beat-to-beat changes in stroke volume from the aortic pulse contour in man. J Appl Physiol 5:495–507

    Google Scholar 

  • Øfsti E (1982) Citalopram — a specific 5-HT-reuptake inhibitor —as an antidepressant drug: A phase II multicenter trial. Prog Neuro-Psychopharmacol Biol Psychiatry 6:327–335

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. The Research Laboratories, H. Lundbeck & Co. A/S, Ottiliavej 7-9, DK-2500, Copenhagen-Valby, Denmark

    V. Boeck, A. Jørgensen & K. Fredricson Overø

Authors
  1. V. Boeck
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. A. Jørgensen
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. K. Fredricson Overø
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Boeck, V., Jørgensen, A. & Fredricson Overø, K. Comparative animal studies on cardiovascular toxicity of tri- and tetracyclic antidepressants and citalopram; relation to drug plasma levels. Psychopharmacology 82, 275–281 (1984). https://doi.org/10.1007/BF00427669

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00427669

Key words

Search

Navigation